It is a fait accompli. Advanced cancers are destined to recur, and drug resistance to single agents is determined simply by how long it takes cancer cells with mutant genes to multiply. That's what a Johns Hopkins team of scientists announced last year when they published findings of experiments with targeted cancer therapies. To overcome drug resistance […]